Validation of diagnostic screening test for pharmacogenomic targets for thiopurine drugs in indian pediatric acute lymphoblastic leukemia patients

The validated ARMS-PCR assay provides a reliable, rapid, and cost-effective platform for simultaneous <i>NUDT15</i> and <i>TPMT 3C</i> genotyping, demonstrating strong concordance with sequencing and clear clinical relevance. Its affordability and minimal infrastructure requirements make it suitable for integration into routine pre-treatment workflows in India, enabling genotype-guided thiopurine dosing and reducing the risk of treatment-related toxicity. This assay supports a scalable path toward equitable implementation of pharmacogenomics in resource-limited pediatric oncology settings.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-12-08
DOI
https://doi.org/10.3389/fphar.2025.1714797
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of diagnostic screening test for pharmacogenomic targets for thiopurine drugs in indian pediatric acute lymphoblastic leukemia patients

George Joseph, Amit Kumar Singh, Saurabh Sharma, Aroonima Misra et al.
Frontiers in Pharmacology
Acute Lymphoblastic Leukemia research
article

Validation of diagnostic screening test for pharmacogenomic targets for thiopurine drugs in indian pediatric acute lymphoblastic leukemia patients

George Joseph, Amit Kumar Singh, Saurabh Sharma, Aroonima Misra, Pranay Tanwar, Raj Kamal, Manpreet Kaur, Sandeep Kumar Swain, Himanshu Dhanda, Prashant Prabhakar, Sufian Zaheer, Bhavika Rishi, Sujit Kumar Verma, Amitabh Singh, Ujjwal Kaushik, Baseer Noor, Sumita Chaudhry, Tejas Somwanshi
article en

Abstract

The validated ARMS-PCR assay provides a reliable, rapid, and cost-effective platform for simultaneous <i>NUDT15</i> and <i>TPMT 3C</i> genotyping, demonstrating strong concordance with sequencing and clear clinical relevance. Its affordability and minimal infrastructure requirements make it suitable for integration into routine pre-treatment workflows in India, enabling genotype-guided thiopurine dosing and reducing the risk of treatment-related toxicity. This assay supports a scalable path toward equitable implementation of pharmacogenomics in resource-limited pediatric oncology settings.

Frontiers in PharmacologyVol. 16
Manipal Academy of Higher Education (IN), Vardhman Mahavir Medical College & Safdarjung Hospital (IN), Jamia Hamdard (IN), Indian Council of Medical Research (IN), National Institute of Child Health (PK), DR. B.R.A. Institute Rotary Cancer Hospital (IN), Institute of Medical Sciences (IN), All India Institute of Medical Sciences (IN)
Postgraduate Institute of Medical Education and Research, Chandigarh, National University of Defense Technology
Openalex Percentile: Top 50%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.